FULC · Categories · Form 3
FULC - SEC Form 3 initial insider statements
Fulcrum Therapeutics Inc. (FULC) sec form 3 initial insider statements - real-time wire coverage filtered to Form 3 only.
Recent Form 3 for FULC
- SEC Form 3 filed by new insider King Rachel K.3 - Fulcrum Therapeutics, Inc. (0001680581) (Issuer)
- New insider Ra Capital Management, L.P. claimed ownership of 10,229,099 shares (SEC Form 3)3 - Fulcrum Therapeutics, Inc. (0001680581) (Issuer)
- New insider Hill Colin claimed no ownership of stock in the company (SEC Form 3)3 - Fulcrum Therapeutics, Inc. (0001680581) (Issuer)
- New insider Horn Patrick Taylor claimed no ownership of stock in the company (SEC Form 3)3 - Fulcrum Therapeutics, Inc. (0001680581) (Issuer)
- SEC Form 3: New insider Musso Alan A claimed no ownership of stock in the company3 - Fulcrum Therapeutics, Inc. (0001680581) (Issuer)
- SEC Form 3 filed by new insider Sapir Alex3 - Fulcrum Therapeutics, Inc. (0001680581) (Issuer)
- SEC Form 3: New insider Arroyo Santiago claimed no ownership of stock in the company3 - Fulcrum Therapeutics, Inc. (0001680581) (Issuer)
- SEC Form 3: New insider Ra Capital Management, L.P. claimed ownership of 7,000,000 shares3 - Fulcrum Therapeutics, Inc. (0001680581) (Issuer)
- SEC Form 3: New insider Hayes Melvin H. Iii claimed no ownership of stock in the company3 - Fulcrum Therapeutics, Inc. (0001680581) (Issuer)
- SEC Form 3: New insider Tourangeau Greg claimed ownership of 12,952 shares3 - Fulcrum Therapeutics, Inc. (0001680581) (Issuer)
- SEC Form 3: New insider Rajavelu Esther claimed no ownership of stock in the company3 - Fulcrum Therapeutics, Inc. (0001680581) (Issuer)
- SEC Form 3: New insider Banks Sonja claimed no ownership of stock in the company3 - Fulcrum Therapeutics, Inc. (0001680581) (Issuer)
- SEC Form 3: Morabito Christopher claimed no ownership of No securities are beneficially owned3 - Fulcrum Therapeutics, Inc. (0001680581) (Issuer)
- SEC Form 3: Judith Dunn claimed no ownership of No securities are beneficially owned3 - Fulcrum Therapeutics, Inc. (0001680581) (Issuer)
- SEC Form 3: Christopher Moxham claimed no ownership of No securities are beneficially owned3 - Fulcrum Therapeutics, Inc. (0001680581) (Issuer)